Loading…
DIA Europe 2019 has ended
View analytic
Wednesday, February 6 • 16:45 - 17:15
#CH303: Repurposing - Working Together on New Uses for Old Drugs

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate

Drug repurposing is the process of identifying new uses for existing medicines in indications outside the scope of the original approved product information. Drug repurposing constitutes a dynamic field of drug development that can offer real benefits to patients. More and more stakeholders are involved in the debate on how repurposing can be best enabled, including academics, patients groups, the European Commission and the pharmaceutical industry. Local initiatives in some countries such as the UK have started to identify possible frameworks to improve access to repurposed medicines for patients. Using case studies, this session will present in an interactive manner what repurposing can be in practice, and the roles the various stakeholders can play. Attendees will get a better understanding of the key aspects that must be taken into consideration to enable repurposing in ways which benefit patients with medicines supported with robust data.

Chair

Sheuli Porkess, MD, MRCP, FFPM


Speakers
SP

Sheuli Porkess

Deputy Chief Scientific Officer, ABPI
Dr Sheuli Porkess is the Deputy Chief Scientific Officer at the Association of the British Pharmaceutical Industry. Sheuli’s career began in clinical medicine in the NHS and subsequently has included a number of medical leadership roles at a national, regional and international... Read More →


Wednesday February 6, 2019 16:45 - 17:15
Content Hub 3 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria